Medivelt
The computed 12-month bankruptcy probability of Medivelt is 0.5% (very low). The 2024 annual accounts show negative equity (€-5k) and a net result of €-9k. Its solvency ranks better than 5% of 6568 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-5k |
| Net result | €-9k |
| Staff (FTE) | 2 |
| Better than sector | 5% |
Mixed profile: strong on profitability, weaker on health.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -78.9% | 66.7% | |
| Net result | €-9k | €46k | |
| Equity | €-5k | €79k | |
| Gross operating margin | €62k | €78k | |
| Staff costs | €69k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | - |
| Net profit | €-9k |
| Cash flow | - |
| Staff costs | €69k |
| Income taxes | - |
| Dividends | - |
| Total assets | €6k |
| Equity | €-5k |
| Debt | €11k |
| of which ≤ 1y | €7k |
| of which > 1y | - |
| Working capital | €-1k |
| Employees (FTE) | 2.0 |
| 2024 | |
|---|---|
| Current ratio | 0.86 |
| Quick ratio | 0.86 |
| Working capital ratio | -16.6% |
| Solvency | -78.9% |
| Debt / equity | -2.27 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -140.3% |
| ROE | 177.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €6k |
| Current assets | 29/58 | €6k |
| Amounts receivable within one year | 40/41 | €750 |
| Cash & bank | 54/58 | €276 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €6k |
| Equity | 10/15 | €-5k |
| Contributions / capital | 10/11 | €4k |
| Accumulated profits (losses) | 14 | €-9k |
| Amounts payable | 17/49 | €11k |
| Amounts payable within one year | 42/48 | €7k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €62k |
| Operating result | 9901 | €-8k |
| Financial charges | 65 | €98 |
| Result before taxes | 9903 | €-9k |
| Net result for the period | 9904 | €-9k |
| Result to be appropriated | 9905 | €-9k |
| NACE primary | General medical practice(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 27-09-2023 |
| Status | Active |
| Postal code | 3020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24111E0248/00V000 | Flanders | 206 m² | 1 · 92 m² | 10.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
04-02-2026 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1000.393.266",
"name_full": "MEDIVELT",
"legal_form": "BV"
}
}04-12-2025 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1000.393.266",
"name_full": "MEDIVELT",
"legal_form": "BV"
}
}29-09-2023 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Dorpsplein 9, 3020 Herent",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0507.839.243",
"name": "bv Dr. Linde Nijns, huisartsenpraktijk"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0507.839.243",
"holder_org_name": "bv Dr. Linde Nijns, huisartsenpraktijk",
"contribution_type": "cash",
"amount_paid_in_eur": 1250,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 1250,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0751.559.859",
"name": "bv Dr. Niels Laes"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0751.559.859",
"holder_org_name": "bv Dr. Niels Laes",
"contribution_type": "cash",
"amount_paid_in_eur": 1250,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 1250,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0669.977.713",
"name": "bv Dr. Elke Polspoel, huisartsgeneeskunde"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0669.977.713",
"holder_org_name": "bv Dr. Elke Polspoel, huisartsgeneeskunde",
"contribution_type": "cash",
"amount_paid_in_eur": 1250,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 1250,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0507.839.243",
"name": "Dr. Linde Nijns, huisartsenpraktijk"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0507.839.243",
"holder_org_name": "Dr. Linde Nijns, huisartsenpraktijk",
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0669.977.713",
"name": "Dr. Elke Polspoel huisartsgeneeskunde"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0669.977.713",
"holder_org_name": "Dr. Elke Polspoel huisartsgeneeskunde",
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0751.559.859",
"name": "Dr. Niels Laes"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen",
"partner_role": null,
"holder_org_kbo": "0751.559.859",
"holder_org_name": "Dr. Niels Laes",
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 3750,
"subject_company": {
"kbo": "1000.393.266",
"name_full": "MEDIVELT",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2023-09-22",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Medivelt |